ResearchGS143, an Inhibitor of E3 Ligase β-TrCP, Reverses HIV-1 Latency Without Activating T Cells via Unconventional Activation of NFκB
ResearchGenetic and Inflammatory Signatures Associated With Worse Prognosis in Hospitalized Patients With Severe SARS-CoV-2 Infection With and Without Diabetes
ResearchOnce-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1: A Phase 2 Randomized Study
ResearchLong-Term Open-Label Vebicorvir for Chronic HBV Infection: Safety and Off-Treatment Responses
ResearchDevelopment of a Dual Channel Detection System for Pan-Genotypic Simultaneous Quantification of Hepatitis B and Delta Viruses
ResearchRelationship Between Body Composition and Serum Immunoglobulin Concentrations after Administration of Intravenous Immune Globulin—Preclinical and Clinical Evidence
ResearchRandomised Phase 2 Study (JADE) of the HBV Capsid Assembly Modulator JNJ-56136379 With or Without a Nucleos(t)ide Analogue in Patients With Chronic Hepatitis B Infection
ResearchSuccessful Treatment of Prosthetic Joint Infection With Single-Stage Exchange and Oral Antibiotics
ResearchThe Association of Serotonin Toxicity with Combination Linezolid-Serotonergic Agent Therapy: A Systematic Review and Meta-Analysis
ResearchComparative Efficacy of Early COVID-19 Monoclonal Antibody Therapies: A Retrospective Analysis
ResearchSafety and Efficacy of Vebicorvir in Virologically Suppressed Patients With Chronic Hepatitis B Virus Infection
ResearchReinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Cohort Study
ResearchSafety and Efficacy of Vebicorvir Administered With Entecavir in Treatment-Naïve Patients With Chronic Hepatitis B Virus Infection
ResearchHealth-Related Quality of Life in People Receiving Opioid Agonist Treatment and Treatment for Hepatitis C Virus Infection
ResearchRisk Factors and Outcomes of Hospitalized Patients With Severe Coronavirus Disease 2019 (COVID-19) and Secondary Bloodstream Infections: A Multicenter Case-Control Study